EU/US regulatory roadmap aims to boost trade:
This article was originally published in Clinica
The European Commission and the US government have developed a Roadmap for EU/US Regulatory Co-operation and Transparency. It outlines a broad range of activities intended to reduce costs, expand market opportunities and help minimise EU/US regulatory differences. Initiatives contained in the Roadmap include improving the regulatory environment, exchanging regulatory work plans and promoting exchanges of regulatory experts. Also proposed is the development of a model confidentiality agreement to support the sharing of confidential information under a range of EU/US regulatory co-operation projects. The Roadmap, as well as the 2002 Guidelines on Regulatory Co-operation and Transparency, are available at: http://europa.eu.int/comm/enterprise/enterprise-policy /gov-relations/interntl-regul-coop-eu-us/index.htm
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.